주식회사케이알바이오텍

{
  "address": "서울특별시 광진구",
  "ceo_name": "김영봉",
  "certificate": [
    {
      "cert_number": "20140103217",
      "changes": "",
      "disclosure_date": "2014-03-26",
      "first_cert_date": "2014-03-26",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2014-03-26 ~ 2016-03-25"
    },
    {
      "cert_number": "20180100030",
      "changes": "",
      "disclosure_date": "2018-01-02",
      "first_cert_date": "2014-03-26",
      "no": "2",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2018-01-02 ~ 2020-01-01"
    },
    {
      "cert_number": "20200101042",
      "changes": "",
      "disclosure_date": "2020-02-05",
      "first_cert_date": "2014-03-26",
      "no": "3",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2020-01-02 ~ 2022-01-01"
    },
    {
      "cert_number": "20220302030041",
      "changes": "",
      "disclosure_date": "2022-03-02",
      "first_cert_date": "2014-03-26",
      "no": "4",
      "type": "혁신성장유형",
      "valid_period": "2022-01-02 ~ 2025-01-01"
    },
    {
      "cert_number": "20250114030029",
      "changes": "",
      "disclosure_date": "2025-01-14",
      "first_cert_date": "2014-03-26",
      "no": "5",
      "type": "혁신성장유형",
      "valid_period": "2025-01-02 ~ 2028-01-01"
    }
  ],
  "company_name": "주식회사케이알바이오텍",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 300000000,
      "cost_of_sales": 24129000,
      "current_assets": 2173403000,
      "current_liabilities": 2201581000,
      "gross_profit": 2316368000,
      "net_income": 687758000,
      "net_income_bs": 582868000,
      "non_current_assets": 3075389000,
      "non_current_liabilities": 68000000,
      "non_operating_expenses": 48140000,
      "non_operating_income": 31276000,
      "operating_profit": 704622000,
      "revenue": 2340497000,
      "sga_expenses": 1611747000,
      "total_assets": 5248792000,
      "total_equity": 2979211000,
      "total_liabilities": 2269581000
    },
    "2023": {
      "capital_stock": 300000000,
      "cost_of_sales": 50932000,
      "current_assets": 2182231000,
      "current_liabilities": 2210942000,
      "gross_profit": 1484991000,
      "net_income": 255329000,
      "net_income_bs": 128335000,
      "non_current_assets": 3118978000,
      "non_current_liabilities": 87000000,
      "non_operating_expenses": 56421000,
      "non_operating_income": 64065000,
      "operating_profit": 247685000,
      "revenue": 1535923000,
      "sga_expenses": 1237306000,
      "total_assets": 5301209000,
      "total_equity": 3003267000,
      "total_liabilities": 2297942000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [],
  "main_products": "바이러스 시험서비스",
  "phone": "02-455-****",
  "years": [
    2023,
    2022
  ]
}